Pangaea Data

Initial Investment



ML Health Tech

Pangaea Data provides a Machine Learning based software product to its customers from the biopharmaceutical and healthcare industries for faster identification of patient cohorts based on their phenotypes (clinical characteristics and symptoms) by machine-reading data from electronic health records (EHRs) and unstructured doctors’ notes.

This activity is critical for detecting patients at risk of diseases, finding genes linked to a phenotype in the context of a drug or biomarker discovery, for recruiting patients for clinical trials and for real-world evidence (RWE) studies.

IQ Capital invested in Pangaea Data at Seed stage in 2019.